Loading stock data…
$108.74-0.52 (-0.48%)
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide.
Xylem Inc. in the Industrials sector is trading at $108.74 with a market capitalization of $28.1B. Wall Street consensus targets $142.62 (16 analysts), implying a +31.2% move over the next 12 months. The stock is currently near its 52-week low of $98.58, remaining 7.7% below its 200-day moving average. On fundamentals, Piotroski 7/9 indicates strong financial quality, Altman Z in the safe zone. Risk note: RSI 72 is overbought against a weak tape. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.34B↑ | $2.13B↓ | $2.40B↑ | $2.27B↓ | $2.30B |
| Gross Profit | $963.00M↑ | $803.00M↓ | $932.00M↑ | $883.00M↓ | $892.00M |
| Operating Income | $401.00M↑ | $275.00M↓ | $386.00M↑ | $357.00M↑ | $331.00M |
| Net Income | $263.00M↑ | $193.00M↓ | $335.00M↑ | $227.00M↑ | $226.00M |
Xylem Inc., together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions for utility, industrial, and residential and commercial building services settings worldwide. It operates through Water...
Academic risk and quality models computed from XYL's own filings and price history, not from analyst opinion.
Strong on 7 of 9 fundamental-health tests covering profitability, leverage and operating efficiency.
Altman Z above the 2.99 safe threshold, so the model puts bankruptcy risk in its lowest band.
Beneish M below the -1.78 flag threshold, so the earnings-manipulation model finds nothing unusual in the accruals and margin trends.
Share of earnings coming from accruals rather than cash. Higher values historically precede weaker future returns.
GARCH(1,1) 30-day annualised forecast, below the current 26.8% reading.
Fama-French 5-factor market beta. The five factors explain 32% of this stock's return variance; the rest is idiosyncratic.
The stock’s own historical valuation anchor, which is a fairer comparison than a sector average for a company with a persistent premium or discount.
Model inputs as of 2026-10-23.